BioNTech to Raise USD 250 Million in Private Placement

    NEXT STORY
    Tiziana Life Sciences Announces Agreement with STC Biologics for GMP Manufacturing of an anti-Interleukin-6-Receptor Monoclonal Antibody for Clinical Studies in Patients with COVID-19
    PREV STORY
    Press release Oncology Venture signs agreement to out-license two pipeline assets as part of prioritized portfolio strategy
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Outlook on the Infectious Disease Molecular Diagnostics Global Market to 2028 – by Product, Technology, End-use, Application and Region

    author_avatar
    NASDAQ Market News

    Oncternal Therapeutics Presents Updated Interim Data for Cirmtuzumab in Combination with Ibrutinib at ASCO 2021

    author_avatar
    NASDAQ Market News

    Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation Plan

    author_avatar
    NASDAQ Market News